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Paediatric Respiratory ReviewsWHY WAS IT IMPORTANT TO DO THIS COCHRANE REVIEW [1]
Cystic ﬁbrosis (CF) is the most common life-shortening
autosomal recessively inherited disease in Caucasian populations
[2]. Progressive respiratory disease in CF results in an abnormal
ventilatory response to exercise which contributes to dyspnea and
is a major limiting factor to exercise tolerance [3]. In addition, a
sedentary lifestyle contributes to the progression of physical and
functional impairment in CF [4], likely with the consequence of a
reduced life expectancy as exercise capacity is linked to survival
[5]. Exercise has received growing recognition among researchers
and clinicians as treatment for chronic disease including CF lung
disease [6,7]. In CF, exercise has the potential to improve airway
clearance through a combination of hyperventilation, mechanical
vibration, and improved sputum viscoelasticity thereby leading to
facilitated and increased sputum expectoration [8,9]. Regular
physical exercise improves exercise tolerance and slows progres-
sive pulmonary function decline [4,10].
Until today, much of the knowledge on the effects of physical
conditioning in CF originates predominantly from observational or
small non-randomized and non-controlled studies. Therefore, a
systematic review of evidence from randomised controlled trials
(RCTs) on the effects of regular physical exercise training was
required to critically evaluate potential beneﬁcial effects on
patient-relevant outcomes in CF.
WHAT COMPARISONS DID WE MAKE IN THIS REVIEW
The primary aim of this review was to assess the effects of
physical exercise training on exercise capacity (e.g., peak oxygen
consumption - VO2peak), pulmonary function (e.g., forced expira-
tory volume at one second - FEV1), and health-related quality of life* Corresponding author. Epidemiology, Biostatistics and Prevention Institute,
University of Zurich, Hirschengraben 84, Zurich, 8001, Switzerland.
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1526-0542/ 2015 Elsevier Ltd. All rights reserved.(HRQoL). Secondary outcomes were CF-related mortality, muscle
strength and anaerobic capacity, further indices of exercise
capacity and pulmonary function, physical activity, body compo-
sition, acute exacerbations, bone health, diabetic control, antibiotic
use, compliance with exercise training and adverse events related
to the exercise intervention or exercise testing as part of the
intervention.
The review included RCTs recruiting participants with CF of any
age and any degree of disease severity, diagnosed on the basis of
clinical criteria and sweat testing or genotype analysis. We included
any type of prescribed physical exercise training (aerobic training or
anaerobic training or a combination of both training regimens)
delivered to individuals with CF compared to usual care. We
excluded studies which involved pure respiratory muscle training.
Two authors independently extracted data and assessed the risk
of bias for each included study according to the Cochrane risk of
bias tool [11].
WHAT WERE THE FINDINGS OF THIS REVIEW?
The review included 13 predominantly small parallel group
RCTs with a total of 402 participants with a wide range of severity
of CF lung disease [12–24]. The study duration ranged from less
than one month up to three years; four studies were short-term
and recruited hospitalised patients [12,22–24] and the other nine
studies were longer term and recruited outpatients [13–21]. There
was wide heterogeneity in study designs with seven studies using
a supervised training approach; ﬁve studies a partially supervised
approach and one study an unsupervised training approach.
The overall risk of bias of the 13 included studies was judged as
low to moderate, due to a combination of unclear reporting of
random sequence generation or allocation concealment (selection
bias) and lack of information regarding blinding of outcome
assessors. None of the included studies was blinded for group
assignment, as it is impossible to blind exercise training. It is
unclear if this could cause bias. training for cystic ﬁbrosis. Paediatr. Respir. Rev. (2016), http://
Figure 1. Comparison of aerobic training (AT) versus no physical training; anaerobic training (ANT) versus no physical training and combined training (CT) versus no physical
training on peak oxygen uptake (VO2peak in mL/min per kg BW).
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sometimes of insufﬁcient duration and combined with additional
treatments such as physiotherapy, nutritional therapy and
intravenous antibiotic treatment in the short-term in-hospital
studies [12,22–24].
Due to different study designs (type of exercise training,
duration etc.), we did not combine results from different studiesPlease cite this article in press as: Radtke T, et al. Physical exercise
dx.doi.org/10.1016/j.prrv.2015.12.004for meta-analysis. One short-term study [12] lasting less than
4 weeks reported improvements in VO2peak and HRQoL, but no
effects on FEV1. The majority of longer-term studies showed
improvements in VO2peak, with unclear effects on FEV1
and HRQoL. Data for VO2peak and FEV1 comparing
physical exercise training versus no exercise training are shown
in Figure 1 and Figure 2, respectively. There was limited training for cystic ﬁbrosis. Paediatr. Respir. Rev. (2016), http://
Figure 2. Comparison of aerobic training (AT) versus no physical training; anaerobic training (ANT) versus no physical training and combined training (CT) versus no physical
training on forced expiratory volume at 1s (FEV1 in % predicted). Please note that the study by Moorcroft et al. [15] is not included in the graph displaying the change in FEV1
(CT versus control), because FEV1 was reported in mL in the original study. This study found no signiﬁcant difference in FEV1 between the training and the control group after
12 months.
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WHAT ARE THE IMPLICATIONS OF THIS REVIEW FOR PRACTICE
AND FOR RESEARCH?
This systematic review showed limited evidence from both
short- and long-term studies that aerobic or anaerobic physical
exercise training or a combination of both has a beneﬁcial effect on
exercise capacity, pulmonary function and HRQoL in individuals
with CF lung disease. However, since physical exercise training
appears to be safe in individuals with CF [25] and is already part of
the regular care offered to most individuals with CF, there is no
reason to discourage exercise training.
The majority of included studies showed methodological
shortcomings. There is a clear need for high-quality randomised
controlled studies with sufﬁcient numbers of study participants
and well-chosen, objectively measurable, reproducible and clini-
cally relevant and participant-oriented outcome measures. Future
studies should focus on the determination of the optimal training
components (e.g. type, frequency, intensity, duration), as well as on
effects of physical exercise training on understudied, but clinically
most relevant outcomes such as bone health, diabetic control,
HRQoL, exacerbations and hospitalisations.
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